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Background: Accessory pathway (AP) ablation is currently performed in
patients with a preexcitation syndrome (PS); natural follow-up is based on old
studies. The purpose of the study was to report data of untreated patients with
PS, studied 2 times at least one year of interval. 
Methods: 2 baseline electrophysiological study (EPS) were performed within
1 to 25 years of one another (mean 9.5±7) in 104 patients, 58 males, 46 females,
aged initially from 4 to 67 y (30±16), with overt PS. First EPS was indicated for
syncope (n=10), atrioventricular reentrant tachycardias (AVRT)(n=51), atrial
fibrillation (AF)(n=6), spontaneous malignant form (AF conducted at very high
rates over AP)(n=4) or for asymptomatic PS (n= 33). The protocol was similar,
performed in control state (CS) and after isoproterenol.
Results: At 2nd EPS, among patients studied for syncope at EPS1, 2 have still
syncope, 3 have AVRT, 1 has AF, 3 are asymptomatic. Among patients with
AVRT at EPS1, 38 (74.5%) have AVRT, 8 are asymptomatic, 3 had syncope, 3
has AF. Among patients with AF, 2 present with a malignant form, 2 had AVRT,
1 is asymptomatic. Among asymptomatic patients, 3 present with a malignant
form, 17 (53%) remain asymptomatic, 7 have AVRT, 4 have syncope, 1 has AF.
All AVRT or AF but 1 occurred in patients with inducible AVRT or AF at EPS1.
The higher rate conducted by AP was lower in CS and after isoproterenol at
EPS2 (166±80bpm, 191±90) than at EPS1 (191±67, 243±67)(p<0.01). AP refrac-
tory periods increased from 268±73ms to 283±62 in CS (p<0.03) and from
202±46 to 244±54ms after isoproterenol (p<0.03). AP has lost anterograde con-
duction properties in 28 patients. AVRT was induced in 5 of 27 asymptomatic
PS with initially negative EPS. Two patients with initially poor anterograde con-
duction over AP have a very rapid conduction over AP several years later.
Conclusions: We generally report an improvement of electrophysiological
data with the time; however AVRT induction remains present in 74.5% of
cases; unexpected changes may occur in 2% of patients considered initially at
low risk who developed a dramatic shortening of AP refractory period several
years after initial measurement. 
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Too often, tachycardias of elderly patients are medically treated without
evaluation of their mechanism. The purpose of the study was to look for the
influence of age on clinical and electrophysiological data and long-term
follow-up of patients with paroxysmal supraventricular tachycardia (SVT). 
Methods: SVT was induced in 1690 patients, 996 females, mean age
49±19 years referred for regular tachycardia. Clinical history, SVT-related
complications, echocardiography, results of electrophysiological study,
methods of treatment were collected. 
Results: 269 patients with SVT were aged from 70 to 97 years (group I),
188 from 70 to 79 (group IA) and 81 from 80 to 97 (group IB). Anticoagulants
were prescribed in 23 for an erroneous diagnosis of atrial tachycardia. They
were compared to 1421 patients <70 years (group II). Heart disease was more
frequent in group I (26%) (group IA:30%, group IB:18%) than in group II
(9%) (p<0.0001). Atypical and typical AV node reentrant tachycardia were
more frequent in group I (94%) than in group II (80%) and concealed acces-
sory pathway was less frequent in group I (6%, Group IA:7%, IB:5%) than in
group II (20%). SVT-related adverse events were more frequent in group I
(26%) (p<0.0001) (group IA:25%,group IB:29%) than in group II (11%).
During follow-up (3±3 years), SVT ablation was indicated more frequently in
group I (73%) (p<0.002) (group IA:73%, group IB:72%) than in group II
(62.5%). SVT ablation-related complications were more frequent in group
IB:7%) (p<0.011) than in group I (3.5%) or IA (4%). Late occurrence of atrial
fibrillation (AF) was more frequent in group IA (10%) than in group II (5%)
(p<0.04) (NS for the group IB (5%). Cardiac deaths were more frequent in
group I (6%) (group IA:4%, group IB: 7.5%) than in group II (2%) (p<0.001). 
Conclusions: SVT-related adverse presentation was frequent in elderly
patients. We recommend the evaluation of regular SVT’s because they can be
related to AVNRT/AVRT. Curative treatment of these tachycardias can be
done despite a risk of ablation-related major complications more frequent after
79 years and a risk of AF development and cardiac death higher in elderly
patients than in younger patients. 
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Background: Slow pathway radiofrequency ablation is used to treat atrio-
ventricular nodal re-entrant tachycardia (AVNRT), but some patients remain
symptomatic. The aim of study was to find predictive clinical factors of
arrhythmias recurrence in symptomatic patients after AVNRT ablation and
risk factors of AF occurrence.
Methods: Slow pathway ablation was performed in 929 patients with
AVNRT and aged 52±18 years. RF energy, 65°, 40 watts was delivered, until
AVNRT was not induced. 
Results: 94 patients were excluded because ablation failed. During follow-
up (mean 2.2±2 years), 136 (16%) had recurrence of symptoms. After invasive
and non-invasive studies, symptoms were related to a sinus tachycardia (n=39)
(5%)( group I), a tachycardia of other origin (atrial fibrillation (AF) (n=54)
(6%) (group II) or AVNRT recurrence (n=43) (5%) (group III); 699 patients
were asymptomatic (84%) (group IV). Group II was older (60±12 years) than
group III (51±20), I (33±15.5), IV (52±18)(p<0.001), less frequently female
(48%) than group I (85%), III (63%), IV (66%)( p<0.001) and had more fre-
quently history of AF (30%) than group I (3%), III (0%) and IV (3%). Other
factors as induction after isoproterenol, mechanism of AVNRT, history of
syncope, number of RF applications, were not different at univariate and
multivariate analysis. A score ≥3 based on age and history of AF (1 for age
45-60 years, 2 for age >60, 3 for history of AF) identified all symptomatic
patients with AF. A score 0 excluded patients with AF-related symptoms.
Patients with only sinus tachycardia and recurrent AVNRT can not be differ-
entiated except by a younger age, in case of sinus tachycardia.
Conclusions: Recurrence of symptoms after successful AVNRT ablation is
relatively frequent (16%), but recurrence of AVNRT is only present in 5% of
patients. A score ≥3 based on age and history of AF identified all patients at
risk of AF. Careful management is required in these patients.
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A long accessory pathway refractory period measured by oesophageal
atrial stimulation is always associated with a benign form of preexci-
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Measurement of accessory pathway (AP) refractory period (RP) is required
for the evaluation of preexcitation syndrome (PS). The purpose of study was
to evaluate the measurement of AP-RP by transesophageal electrophysiolo-
gical study (EPS) and intracardiac EPS.
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Methods: EPS was performed in 51 patients aged from 13 to 50 years
(mean 30±16) for a PS. Atrial stimulation was performed in control state (CS)
at a cycle length of 400ms and coupling was decereased until AP6RP or atrial
RP. Measurement was repeated after isoproterenol when AP-RP≥250ms in
CS. Measurement was performed by transesophageal route and then by intra-
cardiac route, with a delay not >3 months. 
Results: AP-RP’s were 267±50ms in CS, 233±49ms after isoproterenol at
transesophageal EPS, 309±72ms in CS, 280±64ms after isoproterenol at intra-
cardiac EPS (p<0.002). Among 31 patients with initially AP-RP ≥250ms at
transesophageal EPS, AP-RP was ≤220ms after isoproterenol in 12 patients.
All, but one had an AP-RP≥250ms in CS at intracardiac EPS; one patient with
AP-RP of 270ms at esophageal EPS had a value of 240ms at intracardiac EPS
in CS but value was 250ms after isoproterenol. Three patients with trans-
esophageal AP-RP in CS and after isoproterenol ≥280ms had lost their antero-
grade conduction. At transesophageal EPS, AP-RP was <250ms in 20 patients
of which only 8 had a short AP-RP at intracardiac EPS and 3 had a short AP-
RP after isoproterenol. There was no significant difference for the induction
of orthodromic tachycardia at transesophageal and intracardiac EPS (72%) and
there was a similar induction of atrial fibrillation at transesophageal EPS
(32%) and intracardiac EPS (28%).
Conclusions: A long AP refractory period measured at transesophageal
EPS excluded the presence of an AP with a short refractory period at intra-
cardiac study even after isoproterenol. There was an adrenergic factor during
transesophageal EPS and isoproterenol produced a significant shortening of
AP refractory periods in only 39% of patients with AP-RP ≥250ms. When
AP-RP is ≥280ms at transesophageal EPS, the loss of anterograde conduction
in AP can be expected in the following weeks (15%). 
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AV block following radiofrequency (RF) ablation for the treatment of
atrioventricular nodal reentrant tachycardia (AVNRT) is a rare but well reco-
gnised complication of the procedure. The purpose of the study was to report
the long-term follow-up of patients a first d (AVB1), second d (AVB2), or
third d A V block (AVB3) occurred during ablation of AVNRT.
Methods: 930 patients, 615 females, aged from 12 to 92 years, mean age
52±18, had AVNRT. RF energy, 65°, 40 watts was delivered on the slow
pathway, until AVNRT was not induced. 
Results: 94 patients presented a transitory or permanent AVB1,2,3. In 8,
mean age 53±21.5 years, AVB was of vagal origin generally occurring at
femoral puncture (group I). In 26 patients, mean age 46±21, it was traumatic
and regressive occurring either in young patients with a normal conduction
system or in 3 patients with a left bundle branch block. In remaining 60
patients, AVB was directly related to the RF application; AVB was of first
degree in 22 patients aged 56±17 years; it was of 2nd or third degree AVB in
38 patients: in 2 patients AVB3 remained permanent and in all other patients
it was partially or totally regressive. After a follow-up of 2.1±2 years, pace-
maker implantation was implanted in 15 patients, 1 patient with traumatic
AVB3 aged 81 years, 5 patients with AVB3 during ablation, 2 with permanent
AVB3 (0.2%) and 3 with transitory AVB3 and 9 patients without AVB during
ablation. In these last patients, 2 had spontaneous long HV interval. Age of
these patients differed from age of patients with RF-related AVB (73±14 vs
56±17) (p< 0.04). 5 patients with transitory AVB3 remained symptomatic
with alternating slow junctional rhythm and sinus tachycardia. 
Conclusions: AVB remains frequent during AVNRT ablation (10%) but it
is frequently benign and not directly related to the RF application. Permanent
complete AVB is exceptional (0.2%). Patients with transitory complete AVB
remain at high risk of later events as conduction disturbances or sinus
tachycardia. Other AVB’s are age-related and probably without relation with
ablation. Permanent or transitory 1 degree AVB seems without clinical signi-
ficance. 
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Background: Little is known about predictors of high-degree atrioven-
tricular block (AVB) in patients without evidence of advanced His-Pur-
kinje conduction disturbances at electrophysiological study (EPS)
performed for unexplained syncope associated with bundle branch block
(BBB). 
Aims: Identify electrocardiographic predictors of high-degree AVB
during follow-up of these patients. Methods. In this multicenter cohort,
patients were included if they had: (1) unexplained syncope, (2) bundle
branch block (≥120ms), (3) no HPCD at EPS, i.e. baseline HV interval
<70ms, and absence of 2nd- or 3rd-degree AVB induced with atrial pacing
or ajmaline challenge. 
Results: Among the 150 studied patients (72±14 years, 62% male, mean
left ventricular ejection fraction 57±8%), index electrocardiograms showed
right BBB (70%; n=105), left BBB (2.7%; n=41), and nonspecific intraven-
tricular conduction disturbance (3%; n=4). A first-degree AVB was noted in
62 patients (44.3%). During a mean follow-up of 584±88 days, high-degree
AVB was documented in 25 patients (17%). The presence of a first-degree
AVB on the index electrocardiogram was associated with an increased risk
of subsequent high-degree AVB [72% vs. 35%; p<0.01]. Conversely, no
patients with isolated right BBB developed high-degree AVB after a normal
EPS. 
Conclusion: In patients with unexplained syncope associated with BBB,
16% of patients subsequently developed high-degree AVB despite no evi-
dence of advanced HPCD at EPS. This was more likely to occur in patients
with first-degree AVB at presentation. Conversely, this finding never occurred
in patients with isolated RBBB and normal PR interval. 
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Introduction: long QT and related ventricular arrhythmias may complicate
the evolution of Eating Disorders (ED) but duration of QT interval and pre-
valence of long QT in large series of ED patients has not been reported.
Methods: QT intervals were measured in 100 consecutive ED patients
(anorexia nervosa, bulimia nervosa or mixed) in lead II, V2 and V5 and
corrected using Bazett’s formula. 95 healthy subjects matched in age and
gender forms the control group. 
Results: mean age was 30±12 yo and 93% were females. Mean Body
Mass Index (BMI) was 16.9±3kg/m2. Heart rate was significantly lower in
patients with ED (64±14 bpm) compared to controls (78±15 bpm)
(p<0.0001).
QT were significantly longer in ED patients than in controls in leads II
(384±33 vs 366±32, p=0.0003), V2 (377±37 vs 367±35ms, p=0.04) and V5
(381±34 vs 365±30ms, p=0.0005). Corrected QT were significantly shorter in
patients with ED compared to controls in leads II (389±28 vs 412±28ms), V2
(383±27 vs 413±32ms) and V5 (387±26 vs 410±28ms) (p<0.0001 for each
comparison). None of the ED patients had a corrected QT >480 msec (max
